F-star Therapeutics Announces First Patient Dosed in FS222 Phase 1 Clinical Trial

NEXT STORY
Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
PREV STORY
Global Clinical Microbiology Instruments and Reagents Market 2020-2027: Market Size to Reach $6.1 Billion – COVID-19 Serology Race is Getting Bigger and Faster
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock

RANCHO CORDOVA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) ...

author_avatar
NASDAQ Market News

Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

author_avatar
NASDAQ Market News

Palisade Bio Launches Clinical Steering Committee to Provide Clinical Oversight and Guide Preparation for Late-Stage Clinical Trials of LB1148 in Accelerating Postoperative Return of Bowel Function and Reduction of Post-Surgical Adhesions

author_avatar
NASDAQ Market News